Research Article
The Significance of Serum CA-125 Elevation in Chinese Patients with Primary Budd-Chiari Syndrome: A Multicenter Study
Table 1
Clinical data of 243 patients with Budd-Chiari syndrome at diagnosis.
| | | (%) | | Mean ± SD |
| | Acute/chronic* | 31/212 (12.8%/87.2%) | Duration of symptoms before diagnosis (months) | 112.2 ± 109.1 | | Abdominal pain | 52 (21.4%) | Age (years) | 46.3 ± 11.4 | | Distension of abdomen | 73 (30.0%) | Aspartate aminotransferase (U/L) | 41.4 ± 33.6 | | Gastrointestinal bleeding | 42 (17.3%) | Alanine aminotransferase (U/L) | 33.5 ± 26.4 | | Anorexia | 42 (17.3%) | Albumin (g/L) | 37.1 ± 7.6 | | Leg edema | 131 (53.9%) | Alkaline phosphatase (U/L) | 136.5 ± 146.4 | | Leg pigmentation | 108 (44.4%) | Total bilirubin (μmol/L) | 48.5 ± 86.4 | | Leg ulcer | 32 (13.2%) | Direct bilirubin (μmol/L) | 21.6 ± 46.9 | | Abdominal wall distended veins | 125 (51.4%) | Glutamyl peptide transferase (U/L) | 117.6 ± 109.7 | | Leg varices | 105 (43.2%) | Prothrombin time (s) | 14.7 ± 7.2 | | Hepatomegaly | 67 (27.6%) | White blood cell (×109/L) | 4.6 ± 3.4 | | Location of outflow obstruction | | Hemoglobin (g/L) | 117.4 ± 26.3 | | IVCa | 16 (6.6%) | Platelet (×1012/L) | 141.3 ± 97.6 | | HVb | 59 (24.3%) | Alpha fetal protein (ng/mL) | 17.3 ± 74.4 | | Both | 168 (69.1%) | Spleen diameter (cm) | 15.3 ± 3.2 |
|
|
Acute group: duration of symptoms ≤6 months; chronic group: duration of symptoms >6 months.
aHV = hepatic veins; bIVC = inferior vena cava.
|
